Advertisement
Advertisement

BSX

BSX logo

Boston Scientific Corp.

105.36
USD
-0.96
-0.91%
Feb 21, 16:00 UTC -5
Closed
exchange

After-Market

104.6

-0.76
-0.72%

Boston Scientific Corp. Profile

About

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

Info & Links

CEO

Michael F. Mahoney

Headquarters

300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.bostonscientific.com

Auditor

Ernst & Young LLP

Share holders

5,072

Employees

53,000

Boston Scientific Corp. Statistics

Valuation Measures

Market Capitalization2

154.37B

Enterprise Value

164.70B

Enterprise Value/EBITDA(ttm)

38.66

Price to Earnings Ratio(ttm)

41.98

Price to Sales(ttm)

9.29

Price to Book(mrq)

7.06

Price to Cash(ytd)

28.86

Profitability

Gross Margin(ttm)

68.63%

Operating Margin(ttm)

22.25%

Profit Margin(ttm)

11.06%

Return on Equity(ttm)

17.80%

Return on Invested Capital(ttm)

6.12%

Return on Assets(ttm)

9.85%

Income Statement

Revenue(ttm)

16.75B

Revenue Per Share(ttm)

11.35

Gross Profit(ttm)

11.49B

EBITDA(ttm)3

4.26B

Net Income Available to Common(ttm)

1.85B

Diluted EPS(ttm)

1.25

Share Statistics

Beta (5Y Monthly)

0.80

52-Week Change

60.24%

S&P 500 52-Week Change

18.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.48B

Dividend Yield

0.00%

Float4

1.47B

% Held by Insiders

0.50%

% Held by Institutions

89.07%

Balance Sheet

Total Cash(mrq)

414.00M

Total Cash Per Share(mrq)

0.28

Total Debt(mrq)

10.75B

Total Debt/Equity(mrq)

48.84%

Current Ratio(mrq)

1.08%

Quick Ratio(mrq)

1.02%

Book Value Per Share(mrq)

14.92

Cash Flow

Operating Cash Flow Per Share(ytd)

2.31

Free Cash Flow(ytd)

2.65B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement